ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 58 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $445 | +290.4% | 350 | 0.0% | 0.00% | – |
| Q2 2023 | $114 | -24.5% | 350 | 0.0% | 0.00% | – |
| Q1 2023 | $151 | -18.8% | 350 | 0.0% | 0.00% | – |
| Q4 2022 | $186 | – | 350 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 350 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 350 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -99.9% | 350 | 0.0% | 0.00% | – |
| Q1 2021 | $1,628,000 | +162700.0% | 350 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 350 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -33.3% | 350 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $3,000 | -40.0% | 350 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $5,000 | +150.0% | 350 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $2,000 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |